Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
A joint MRC/European Organisation for Research and Treatment of Cancer (EORTC) study of radiotherapy for low grade astrocytomas and oligodendrogliomas
ISRCTN ISRCTN17931175
DOI 10.1186/ISRCTN17931175
ClinicalTrials.gov identifier
EudraCT number
Public title A joint MRC/European Organisation for Research and Treatment of Cancer (EORTC) study of radiotherapy for low grade astrocytomas and oligodendrogliomas
Scientific title
Acronym N/A
Serial number at source BR04
Study hypothesis To assess the value of post-operative radiotherapy in the management of low grade (1 & 2) astrocytoma and oligodendroglioma.
Lay summary http://www.ctu.mrc.ac.uk/research_areas/study_details.aspx?s=100
Ethics approval Not provided at time of registration.
Study design Randomised controlled trial
Countries of recruitment Europe
Disease/condition/study domain Cancer
Participants - inclusion criteria 1. Age 16-66
2. World Health Organisation (WHO) performance status 0-2
3. Neurosurgery within past 8 weeks
4. No previous malignancy
5. No previous treatment except surgery
6. Corticosteroids, anticonvulsants or diuretics
7. No condition likely to prejudice treatment or follow up
Participants - exclusion criteria History of cardiac disease
Anticipated start date 01/08/1986
Anticipated end date 30/06/1996
Status of trial Completed
Patient information material
Target number of participants 250
Interventions Two groups - post-operative radiotherapy and no post-operative radiotherapy.
Primary outcome measure(s) Survival time, Morbidity, Time to progression
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Medical Research Council (MRC) (UK)
Trial website
Publications 2005 results in http://www.ncbi.nlm.nih.gov/pubmed/16168780
Contact name Dr  Hannah  Brooks
  Address MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
  Email
Sponsor Medical Research Council (MRC) (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 28/02/2001
Last edited 04/08/2011
Date ISRCTN assigned 28/02/2001
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.